uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted April 21, 2018

NxtGen Botanicals Maeng Da Kratom Recalled

On April 18, 2018, NGB Corp. of West Jordan, Utah issued a recall of NxtGen Botanicals Maeng Da Kratom labeled bottles of encapsulated product because they have the potential to be contaminated with Salmonella. To date, one illness has been reported to the FDA.

Salmonella is an organism that has been linked to fatal infection in young children, frail or elderly adults, and people with weakened immune systems. In healthy adults, Salmonella can produce fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare cases, Salmonella infection can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis. In February 2018, the CDC warned consumers not to use kratom in any form as it began investigating an outbreak of illness caused by Salmonella infection associated with the use of kratom.

The recalled kratom products were sold directly to 22 retailers in Utah, 2 in Massachusetts, and 1 in each of Arizona, Georgia, Minnesota, and California. They are packaged in plastic sealed bottles sold in 500-milligram capsules and can be identified by the following:
  • Product Name: NxtGen Botanicals Maeng Da Kratom

  • Packaging: plastic sealed bottles sold in 500-milligram capsules

  • Lot #: 171409
Consumers who have purchased the products listed above should discontinue use of the product and may return the unused portion to the place of purchase for a full refund.

Kratom, also known as Thang, Kakuam, Thom, Ketom, and Biak, is often sold as powdered leaves or extract in loose powder, tea, capsules or liquids, and is promoted for energy, pain relief or to help ease opioid withdrawal. Consumption of kratom has also been associated with adverse effects, including hepatotoxicity, psychosis, seizure, weight loss, insomnia, tachycardia, vomiting, poor concentration, hallucinations, and death, associated with its opioid properties.

See these related warnings:

NutriZone Expands Recall of Kratom Products

Kratom Powders and Capsules Recalled Due to Salmonella Risk

FDA Issues Mandatory Recall of Salmonella-Contaminated Kratom Products

NutriZone Kratom Supplements Recalled Due to Salmonella Risk

More Kratom Supplements Recalled Due to Salmonella Risk

PDX Aromatics Expands Recall of Kratom Products

Kratom Supplements Recalled and Destroyed

Salmonella Outbreak Linked to Kratom Powders, Pills and Teas

FDA Links 44 Deaths to Kratom

36 Deaths Associated With the Use of Kratom Products

Police Officer Dies From Kratom Overdose, Herb Currently Legal in Most States

Seller of Supplements for Opiate Withdrawal Warned for Drug Claims

Kratom To Be Classified a Schedule I Controlled Substance

To see the complete recall, use the link below.